Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Fight ALD


Address

P.O. Box 3318
Vista, CA 92085

Phone

7602125731

Email Address

info@fightald.org

Description

The Fight ALD is dedicated to fighting illness through education. Specifically, its members work to increase awareness of adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMM) among medical professionals and the public. Symptoms of these disorders often are misdiagnosed or go undetected, limiting treatment options and leading to life-threatening situations. Adrenoleukodystrophy is an inherited metabolic disorder that causes damage to the myelin sheath that that surrounds nerve cells in the brain. AMM is the name given to the adult-onset form of ALD, and usually involves the myelin sheath of the spinal cord rather than the brain.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.